Clinical Trial: Study of Varsetatug Masetecan in Combination With Anti-Cancer Therapies in Colorectal Cancer

U.S., Oct. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07900165) titled 'Study of Varsetatug Masetecan in Combination With Anti-Cancer Therapies in Colorectal Cancer' on Oct. 21.

Brief Summary: This is a non-registrational Phase 1/2, multicenter, open-label trial to evaluate the efficacy and safety of varsetatug masetecan combined with anti-cancer therapies in participants with unresectable metastatic colorectal cancer in the second line treatment setting.

Study Start Date: Dec., 2026

Study Type: INTERVENTIONAL

Condition: Colo-rectal Cancer

Intervention: DRUG: varsetatug masetecan

Investigational Product

DRUG: bevacizumab + 5-FU + leucovorin

IV infusion

DRUG: bevacizumab

IV infusion

Recruitme...